Study Summary
This trial will test an experimental treatment for tinnitus in 250 adults to see if it is safe and effective.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 6 weeks
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
MHNA-003
1 of 1
Experimental Treatment
250 Total Participants · 1 Treatment Group
Primary Treatment: MHNA-003 · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Georgia | 50.0% |
| California | 50.0% |
What portion of applicants met pre-screening criteria?
| Did not meet criteria | 50.0% |
| Met criteria | 50.0% |
What site did they apply to?
| Mahana Therapeutics | 100.0% |
How many prior treatments have patients received?
| 0 | 100.0% |
Frequently Asked Questions
What is the upper limit of participants in this experiment?
"Affirmative. The information on clinicaltrials.gov verifies that this medical trial is currently looking for participants. It was initially posted on December 19th 2022, and has been recently modified in January 13th 2023. A total of 250 patients need to be recruited from one research centre." - Anonymous Online Contributor
Are new participants able to register for this research endeavor?
"Affirmative. Per the data found on clinicaltrials.gov, this medical research is actively searching for participants and was first brought to light on December 19th 2022 with a recent update made January 13th 2023. A total of 250 individuals must be recruited from one site in order to fulfill the requirements set forth by the trial." - Anonymous Online Contributor